Gmbh v. Mizuho USA, Inc.
This text of 74 F. App'x 895 (Gmbh v. Mizuho USA, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
ON MOTION
ORDER
Mizuho USA, Inc. moves for reconsideration of the court’s order dismissing its appeal, 03-1390.
Mizuho’s appeal 03-1390 was consolidated with a related case, Inverness v. Pfizer, Inc., 03-1391. Inverness and Pfizer settled their dispute and the court granted Inverness’ and Pfizer’s joint motion to dismiss voluntarily 03-1390, -1391. However, Mizuho was not a party to the motion to dismiss and thus its appeal should not have been dismissed based on that motion.
Accordingly,
IT IS ORDERED THAT:
(1) Mizuho’s motion for reconsideration is granted.
(2) The June 16, 2003 dismissal order is vacated, the mandate is recalled, and the appeal is reinstated.
(3) The revised official caption is reflected above.
(4) The briefing schedule is stayed pending the court’s ruling on Inverness’ motion to dismiss.
The court will rule on Inverness Medical Switzerland GmbBH et al.’s motion to dismiss in a separate order.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
74 F. App'x 895, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gmbh-v-mizuho-usa-inc-cafc-2003.